ANI Pharmaceuticals, Inc. (ANIP)
77.75
+3.54
(+4.77%)
USD |
NASDAQ |
Apr 06, 13:56
ANI Pharmaceuticals SG&A Expense (TTM) : 317.74M for Dec. 31, 2025
SG&A Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (TTM) Benchmarks
| Liquidia Corp. | 157.18M |
| Catalyst Pharmaceuticals, Inc. | 171.18M |
| Indivior Pharmaceuticals, Inc. | 635.00M |
| Replimune Group, Inc. | 103.07M |
| ADMA Biologics, Inc. | 96.42M |